|
RPL36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.178100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.572740E-04 |
| Normal-vs-Stage2 |
1.614360E-01 |
| Normal-vs-Stage3 |
1.604580E-04 |
| Normal-vs-Stage4 |
6.44579999999895E-05 |
| Stage1-vs-Stage2 |
4.479800E-01 |
| Stage1-vs-Stage3 |
2.004000E-01 |
| Stage1-vs-Stage4 |
1.818800E-01 |
| Stage2-vs-Stage3 |
1.428550E-01 |
| Stage2-vs-Stage4 |
1.486960E-01 |
| Stage3-vs-Stage4 |
9.754400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.400200E-04 |
| Normal-vs-AfricanAmerican |
1.347780E-02 |
| Normal-vs-Asian |
6.217000E-04 |
| Caucasian-vs-AfricanAmerican |
9.371800E-01 |
| Caucasian-vs-Asian |
6.224400E-01 |
| AfricanAmerican-vs-Asian |
7.917800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.56039999999714E-05 |
| Normal-vs-Female |
6.213300E-04 |
| Male-vs-Female |
9.964600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.427290E-04 |
| Normal-vs-Age(41-60Yrs) |
1.342230E-03 |
| Normal-vs-Age(61-80Yrs) |
4.164300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.521800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.169800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.775200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.053700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.988200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.489360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.990640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.217800E-01 |
| Classical-VS-Follicular |
2.581400E-03 |
| Classical-VS-Other |
7.271200E-01 |
| Classical-VS-Normal |
6.03179999999481E-05 |
| Tall-VS-Follicular |
2.644300E-02 |
| Tall-VS-Other |
6.909800E-01 |
| Tall-VS-Normal |
3.495500E-03 |
| Follicular-VS-Other |
1.918380E-01 |
| Follicular-VS-Normal |
1.759820E-01 |
| Other-VS-Normal |
3.972500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.419900E-04 |
| Normal-vs-N1 |
3.029700E-04 |
| N0-vs-N1 |
1.309190E-01 |
|
|
